CV Sciences (CVSI) Share-based Compensation (2011 - 2026)
CV Sciences (CVSI) posted Share-based Compensation of $1.1 million for Q1 2026, up 794.31% sequentially from $123000.0 in Q4 2025, and up 832.2% YoY from $118000.0 in Q1 2025.
CV Sciences (CVSI) Share-based Compensation (2011 - 2026) Analysis & Trends
CV Sciences has reported Share-based Compensation for 14 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Share-based Compensation rose 832.2% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 285.96% YoY) and the FY2025 annual result came in at $700000.0, changed 0.0% from the prior year.
- Share-based Compensation rose to $1.1 million in Q1 2026 per CVSI's latest filing, from $123000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $1.1 million in Q1 2026 and troughed at -$171000.0 in Q2 2022.
- A 5-year average of $381375.0 and a median of $120500.0 in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation sank 118.75% in 2022, then surged 2471.43% in 2024.
- Over 5 years, Share-based Compensation stood at $664000.0 in 2022, then tumbled by 95.03% to $33000.0 in 2023, then soared by 215.15% to $104000.0 in 2024, then climbed by 18.27% to $123000.0 in 2025, then jumped by 794.31% to $1.1 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $1.1 million, $123000.0, and $800000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 900,000.00 |
| Jun 30, 2026 | 900,000.00 |
| Mar 31, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 123,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |